Phase II 2-arm trial of the proteasome inhibitor, PS-341 (bortezomib) in combination with irinotecan or PS-341 alone followed by the addition of irinotecan at time of progression in patients with locally recurrent or metastatic squamous cell carcinoma of

Faculty Opinions recommendation of Phase II 2-arm trial of the proteasome inhibitor, PS-341 (bortezomib) in combination with irinotecan or PS-341 alone followed by the addition of irinotecan at time of progression in patients with locally recurrent or metastatic squamous cell carcinoma of the head and neck (E1304): a trial of the Eastern Cooperative Oncology Group.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717954085.793459863 ◽

2012 ◽

Author(s):

Marco Merlano

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Proteasome Inhibitor ◽

Eastern Cooperative Oncology Group ◽

Oncology Group ◽

Phase II Trial of Interferon-?? in Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: Immunological and Clinical Correlates

Journal of Immunotherapy ◽

10.1097/00002371-199611000-00008 ◽

1996 ◽

Vol 19 (6) ◽

pp. 433-442 ◽

Cited By ~ 23

Author(s):

Daniel R. Vlock ◽

Janet Andersen ◽

Leslie A. Kalish ◽

Jonas T. Johnson ◽

John M. Kirkwood ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Trial ◽

Clinical Correlates ◽

Faculty Opinions recommendation of Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: clinical activity and molecular response (GORTEC 2008-02).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.14264023.15777137 ◽

2012 ◽

Author(s):

Marco Merlano

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Clinical Activity ◽

Molecular Response ◽

Faculty Opinions recommendation of Cetuximab and bevacizumab: preclinical data and phase II trial in recurrent or metastatic squamous cell carcinoma of the head and neck.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717954885.793461177 ◽

2012 ◽

Author(s):

Sandra Nuyts

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Trial ◽

Preclinical Data ◽

Docetaxel, cisplatin, and 5-fluorouracil (DCF) chemotherapy in the treatment of metastatic or unresectable locally recurrent anal squamous cell carcinoma: A phase II study of French interdisciplinary GERCOR and FFCD Groups (Epitopes-HPV02 study)

Annals of Oncology ◽

10.1093/annonc/mdx393.062 ◽

2017 ◽

Vol 28 ◽

pp. v181

Author(s):

S. Kim ◽

E. Francois ◽

F-C. Bidard ◽

E. Samalin ◽

F. El Hajbi ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Anal Squamous Cell Carcinoma ◽

Phase II study of vinorelbine/cetuximab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck progressing after at least two chemotherapy regimens

Oral Oncology ◽

10.1016/j.oraloncology.2010.08.013 ◽

2010 ◽

Vol 46 (11) ◽

pp. 818-821 ◽

Cited By ~ 8

Author(s):

Elena Massa ◽

Mariele Dessì ◽

Giulio Gaspardini ◽

Federica Saba ◽

Valeria Cherchi ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Radiotherapy and Cisplatin in Metastatic Squamous Cell Carcinoma of an Unknown Primary Tumor Localized to the Neck. A Phase II Study

Journal of Chemotherapy ◽

10.1080/1120009x.1992.11739199 ◽

1992 ◽

Vol 4 (6) ◽

pp. 399-402 ◽

Cited By ~ 7

Author(s):

B. Jeremic ◽

L.J. Zivic ◽

S. Jevremovic

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Primary Tumor ◽

Phase Ii Study ◽

Unknown Primary ◽

Unknown Primary Tumor ◽

Treatment of Locally Recurrent and Metastatic Squamous Cell Carcinoma of Head & Neck

Head and Neck Cancer Research ◽

10.21767/2572-2107.100004 ◽

2016 ◽

Vol 01 (01) ◽

Author(s):

Chukwuemeka V Ikpeazu

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Squamous Cell ◽

Locally Recurrent ◽

Head Neck

Cabazitaxel in recurrent/metastatic squamous cell carcinoma of the head and neck: phase II UNICANCER trial ORL03

Oncotarget ◽

10.18632/oncotarget.15901 ◽

2017 ◽

Vol 8 (31) ◽

pp. 51830-51839 ◽

Cited By ~ 2

Author(s):

Jerome Fayette ◽

Joel Guigay ◽

Christophe Le Tourneau ◽

Marian Degardin ◽

Frederic Peyrade ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

A phase II study of vinorelbine (VRL), cisplatin (CDDP) and 5-Fluorouracil (FU) in patients (PTS) with locally advanced recurrent, and/or metastatic squamous cell carcinoma of the head and neck (SCCHN)

European Journal of Cancer ◽

10.1016/s0959-8049(99)81098-3 ◽

1999 ◽

Vol 35 ◽

pp. S176

Author(s):

V. Guillem ◽

M.A. Muñoz ◽

R. Yaya ◽

V. Soriano ◽

M.A. Climent ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Locally Advanced ◽